Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $11.00

Aveanna Healthcare (NASDAQ:AVAH) had its price objective upped by Truist Financial from $9.00 to $11.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the stock. Truist Financial’s price objective points to a potential upside of 15.42% from the company’s current price.

AVAH has been the topic of a number of other reports. Barclays boosted their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price target for the company in a report on Wednesday, June 3rd. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective on the stock in a report on Friday, March 20th. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Finally, BMO Capital Markets cut their target price on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research note on Friday, March 20th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $10.78.

Aveanna Healthcare Trading Down 1.4%

Aveanna Healthcare stock opened at $9.53 on Tuesday. Aveanna Healthcare has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. The stock has a market capitalization of $2.08 billion, a P/E ratio of 8.08, a PEG ratio of 0.96 and a beta of 1.89. The stock has a 50-day simple moving average of $7.72 and a 200 day simple moving average of $7.59.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.05. The firm had revenue of $647.91 million for the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The business’s quarterly revenue was up 15.9% compared to the same quarter last year. Analysts expect that Aveanna Healthcare will post 0.68 earnings per share for the current year.

Insider Transactions at Aveanna Healthcare

In related news, insider Patrick A. Cunningham sold 125,000 shares of Aveanna Healthcare stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total transaction of $948,750.00. Following the completion of the sale, the insider directly owned 212,755 shares of the company’s stock, valued at approximately $1,614,810.45. This trade represents a 37.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 3,000,000 shares of the business’s stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total value of $24,030,000.00. Following the completion of the sale, the insider owned 190,130 shares of the company’s stock, valued at $1,522,941.30. This trade represents a 94.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 31,305,664 shares of company stock valued at $215,555,910. 5.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Aveanna Healthcare

Several institutional investors and hedge funds have recently modified their holdings of AVAH. Vanguard Group Inc. raised its stake in Aveanna Healthcare by 38.0% in the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after purchasing an additional 1,535,351 shares in the last quarter. Millennium Management LLC grew its position in shares of Aveanna Healthcare by 1,007.1% during the 4th quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after purchasing an additional 1,014,030 shares in the last quarter. Nuveen LLC grew its position in shares of Aveanna Healthcare by 135.9% during the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after purchasing an additional 905,316 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of Aveanna Healthcare by 451.3% during the third quarter. Arrowstreet Capital Limited Partnership now owns 959,488 shares of the company’s stock worth $8,511,000 after purchasing an additional 785,452 shares during the period. Finally, Zimmer Partners LP bought a new position in shares of Aveanna Healthcare during the fourth quarter worth approximately $6,189,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.